Inventor · disambiguated record
Andrew C. Phillips
Also filed as: PHILLIPS ANDREW · PHILLIPS ANDREW C
8 granted patents·29 pending applications·85 citations·filing 2009–2024
85Inventor score
Top patents by PatentIndex Score
37 records- 0195US9493568B2Anti-EGFR antibodies and antibody drug conjugatesABBVIE INC·Filed 2015·Granted Nov 15, 2016·19 cites·22 claims
- 0294US9029508B2Dual variable domain immunoglobulins and uses thereofGHAYUR TARIQ·Filed 2009·Granted May 12, 2015·57 cites·22 claims
- 0389US11633497B2Anti-c-Met antibody drug conjugatesABBVIE INC·Filed 2022·Granted Apr 25, 2023·1 cites·8 claims
- 0488US2025163159A1Anti-egfr antibodies and antibody drug conjugatesABBVIE INC·Filed 2024·Application pending·0 cites
- 0585US9827330B2Anti-EGFR antibodies and antibody drug conjugatesABBVIE INC·Filed 2016·Granted Nov 28, 2017·3 cites·21 claims
- 0684US10640563B2Anti-B7-H3 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Granted May 5, 2020·3 cites·3 claims
- 0783US10098968B2Anti-EGFR antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Granted Oct 16, 2018·2 cites·13 claims
- 0881US2025213685A1Anti-egfr antibody drug conjugatesABBVIE INC·Filed 2024·Application pending·0 cites
- 0981US2025263491A1Anti-egfr antibody drug conjugatesABBVIE INC·Filed 2024·Application pending·0 cites
- 1078US2025170263A1Anti-egfr antibody-drug conjugatesABBVIE INC·Filed 2024·Application pending·0 cites
- 1178US2022288221A1Anti-egfr antibodies and antibody drug conjugatesABBVIE INC·Filed 2021·Application pending·0 cites
- 1275US2024115725A1Anti-EGFR Antibody-Drug ConjugatesABBVIE INC·Filed 2023·Application pending·0 cites
- 1374US11759527B2Anti-EGFR antibody-drug conjugatesABBVIE INC·Filed 2022·Granted Sep 19, 2023·0 cites·3 claims
- 1474US2024199745A1Anti-egfr antibody drug conjugatesABBVIE INC·Filed 2023·Application pending·0 cites
- 1573US2023372519A1Anti-c-met antibody drug conjugatesABBVIE INC·Filed 2023·Application pending·0 cites
- 1672US2023114718A1Anti-egfr antibody drug conjugatesABBVIE INC·Filed 2022·Application pending·0 cites
- 1771US2020405878A1Anti-egfr antibodies and antibody drug conjugatesABBVIE INC·Filed 2020·Application pending·0 cites
- 1870US2023077680A1Anti-egfr antibody drug conjugatesABBVIE INC·Filed 2021·Application pending·0 cites
- 1967US2025032631A1Anti-sez6 antibody drug conjugatesABBVIE INC·Filed 2024·Application pending·0 cites
- 2066US2019134216A1Anti-egfr antibodies and antibody drug conjugatesABBVIE INC·Filed 2018·Application pending·0 cites
- 2165US2023135723A1Anti-cd98 antibodies and antibody drug conjugatesABBVIE INC·Filed 2022·Application pending·0 cites
- 2264US2024091374A1Anti-sez6 antibody drug conjugatesABBVIE INC·Filed 2023·Application pending·0 cites
- 2364US2023120736A1Anti-cd98 antibodies and antibody drug conjugatesABBVIE INC·Filed 2022·Application pending·0 cites
- 2457US2019153108A1Anti-egfr antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 2557US2021171637A1Anti-b7-h3 antibodies and antibody drug conjugatesABBVIE INC·Filed 2020·Application pending·0 cites
- 2653US2019343961A1Anti-egfr antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 2752US2020121803A1Anti-cd98 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 2851US2010260668A1Dual Variable Domain Immunoglobulins and Uses ThereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 2951US2011313230A1Specific binding proteins and uses thereofJOHNS TERRANCE GRANT·Filed 2011·Application pending·0 cites
- 3051US2015104452A1Dual variable domain immunoglobulins and uses thereofABBVIE INC·Filed 2014·Application pending·0 cites
- 3148US2019153107A1Anti-egfr antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 3247US12116411B2Antibodies binding to human CD3 at acidic pHABZYME THERAPEUTICS LLC·Filed 2021·Granted Oct 15, 2024·0 cites·15 claims
- 3347US2020147235A1Anti-cd98 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 3443US2020338209A1Anti-b7-h3 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 3543US2020002432A1Anti-cd98 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 3642US2011293511A1Specific binding proteins and uses thereofJOHNS TERRANCE GRANT·Filed 2011·Application pending·0 cites
- 3739US2020002421A1Anti-b7-h3 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew C. Phillips files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →